Drug Topics
MARCH 26, 2025
Jasmine Cutler, PharmD, CPh, assistant professor in the department of pharmacy practice at the Taneja College of Pharmacy, discusses role of education and accessibility in reproductive health.
PharmaVoice
MARCH 26, 2025
A delay of the prescription-to-OTC rule signals health agencies’ ongoing reluctance to implement new regulations.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Drug Topics
MARCH 26, 2025
Susan Cornell, PharmD, CDCES, FAPhA, FADCES, associate director of experiential education at the College of Pharmacy at Midwestern University, also addresses personalized care and the expanding responsibilities of pharmacists.
Fierce Healthcare
MARCH 26, 2025
The Centers for Disease Control and Prevention is reportedly rescinding $11.4 billion in funds to states, cities and organizations receiving grants for COVID-19 efforts.
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Drug Topics
MARCH 26, 2025
Experts discuss what they learned at the American Pharmacists Association Annual Meeting and Exposition 2025.
Pharmacy Times
MARCH 26, 2025
Older age and being insured with Medicare or Medicaid were associated with heightened annual joint bleeding rates, whereas treatment in the Northeast United States improved outcomes in both hemophilia A and hemophilia B.
Pharmacy Technician Pulse brings together the best content for pharmacy technicians from the widest variety of industry thought leaders.
Pharmacy Times
MARCH 26, 2025
Patients with chronic lymphocytic leukemia (CLL) show weakened T-cell memory responses to COVID-19 vaccination.
Fierce Healthcare
MARCH 26, 2025
To prepare for the expansion, Two Chairs has added new clinicians to its team, including some who are cross-licensed to treat in multiple states. To date, the company focused on building its presence in California, Florida and Washington, where it also has in-person clinics.
pharmaphorum
MARCH 26, 2025
Recent financings in the biotech space include rounds for Character Bio, Tempero, Epicrispr, Hillstar Bio, and Ampersand Biomedicines
Fierce Healthcare
MARCH 26, 2025
Private equity's track record in healthcare could best be described as "mixed," with high-profile failures like the implosion of Steward Health Care setting a poor example. | Private investment will be even more critical for healthcare organizations in a political environment where public funds are likely to shrink.
Speaker: Chris Antypas and Josh Halladay
Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.
Pharmaceutical Technology
MARCH 26, 2025
Sanofi will commence a Phase I/II trial with its vaccine candidate in the next few days to start generating immunogenicity data.
Pharmacy Times
MARCH 26, 2025
Adding daratumumab improved minimal residual disease (MRD) negativity rates, leading to superior progression-free survival (PFS).
pharmaphorum
MARCH 26, 2025
The UK is providing 2m in funding to allow digital assessment to be added to a highly-anticipated trial of blood tests for diagnosing dementia
Pharmacy Times
MARCH 26, 2025
About 59.2% of patients with tardive dyskinesia (TD) who completed the 48-week trial achieved remission.
Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist
What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.
Pharmaceutical Commerce
MARCH 26, 2025
Jen Butler, chief commercial officer, Pleio, discusses how the companys GoodStart programs help patients navigate specialty pharmacies.
Pharmacy Times
MARCH 26, 2025
Will traditional PBMs adapt, or will disruptors take over?
Pharmaceutical Commerce
MARCH 26, 2025
The Beijing location represents the sixth worldwide.
Pharmacy Times
MARCH 26, 2025
Using Janus kinase inhibitors, having experienced a previous thrombosis episode, and higher age were associated with a heightened risk of a new thromboembolic event.
Advertisement
Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.
Pharmaceutical Technology
MARCH 26, 2025
Multinational companies in Chinas vaccine market face headwinds amid an anti-corruption crackdown and rising competition.
Pharmacy Times
MARCH 26, 2025
Community health workers improve patient care and address health care access gaps.
Pharmaceutical Commerce
MARCH 26, 2025
The latest news for pharma industry insiders.
Pharmacy Times
MARCH 26, 2025
The hepatitis B core-related antigen (HBcrAg) rapid diagnostic test was more timely and showed a stronger sensitivity and specificity compared with other testing methods.
Fierce Healthcare
MARCH 26, 2025
Dual-eligible beneficiaries are among the most expensive and complex patients out there. | Pair Team supports community-based organizations via California's Medi-Cal Community Care Hubs model.
Pharmacy Times
MARCH 26, 2025
Patients achieved statistically significant benefits in progression-free survival and overall response rates.
pharmaphorum
MARCH 26, 2025
The FDA has approved GSK's Blujepa, the first new-mechanism oral antibiotic for uncomplicated UTIs in nearly 30 years, after a priority review
Pharmacy Times
MARCH 26, 2025
In previously sedentary young males and females, 14 days of moderate aerobic exercise increased red and white blood cell counts and hemoglobin concentrations without altering key cardiometabolic enzymes.
pharmaphorum
MARCH 26, 2025
The growing burden of misinformation: Patients left wondering where to turn for trusted insights and support Mike.
Pharmacy Times
MARCH 26, 2025
The findings provide a deeper understanding of the mechanisms underlying breast cancer progression and treatment resistance.
Pharmaceutical Technology
MARCH 26, 2025
EU member states are set to launch the EU Health Data Space Regulation for harmonised data transfer on 26 March.
PharmExec
MARCH 26, 2025
OncLive serves as the connection to oncology, including groundbreaking cancer news and interviews with top oncologists in multimedia formats.
Pharmaceutical Technology
MARCH 26, 2025
Ensuring the highest standards in pharmaceutical logistics is crucial for patient safety and treatment efficacy.
PharmExec
MARCH 26, 2025
Results from multiple clinical trials showed that Tagrisso demonstrated survival benefits in EGFR-mutated non-small cell lung cancer, both as monotherapy and in combination therapies.
Pharmaceutical Technology
MARCH 26, 2025
While Cassava is stopping investigations into simufilam in Alzheimers disease, the therapy is now being evaluated in TSC-related epilepsy.
Expert insights. Personalized for you.
316 
Let's personalize your content